---
title: "Urate targets, blood tests, and follow-up"
canonical_url: https://www.gout-life.com/treatments/targets-monitoring-and-follow-up/
updated: 2026-10-29
medical_review: pending
---

# Urate targets, blood tests, and follow-up

> General educational information, not medical advice, diagnosis, or treatment.

Pain matters, but it does not tell the whole treatment story. Follow-up should consider blood urate, flares, tophi, movement, side effects, kidney health, and whether you can obtain and take the medicine. A quiet stretch does not prove urate is controlled, and early flares do not automatically mean treatment is failing. [S02] [S03]

## Know your target—and its unit

The usual gout treatment target is **below 6 mg/dL**, approximately **360 µmol/L** in guideline convention. NICE considers below 5 mg/dL (300 µmol/L) for tophi, chronic gouty arthritis, or frequent flares continuing despite the usual target. A laboratory’s reference interval and your gout treatment target are different things. [S02] [S03]

## Expect checks while the dose changes

NICE uses monthly urate results to guide dose increases until target is reached, then considers annual urate monitoring during continuing treatment. ACR supports repeat urate-guided adjustment with a practical schedule tailored to the regimen. Kidney and liver tests and blood counts depend on your medicine and circumstances; urate is not the whole safety check. [S02] [S03] [S09]

## Ask about early-flare prevention

ACR recommends anti-inflammatory prevention for at least three to six months when ULT begins, with reassessment and extension if attacks continue. NICE discusses prevention while target urate is being reached. Interactions, tolerance, and kidney function influence the choice. [S02] [S03]

## Bring a useful record

Keep the date, urate value, unit, dose at the time, and whether a flare was occurring. Note attacks and side effects separately. Raise missed doses, confusing directions, or refill problems openly. A simpler or more accessible plan may be more useful than another instruction you cannot realistically follow. [S03]

## Related pages

- [Uric acid, urate and purines](https://www.gout-life.com/learn/uric-acid-and-purines/)
- [Urate-lowering therapy and prevention](https://www.gout-life.com/treatments/urate-lowering-therapy/)
- [Flare and urate record](https://www.gout-life.com/tools/flare-and-urate-tracker/)
- [Appointments, treatment access and your care team](https://www.gout-life.com/living/appointments-cost-and-care-team/)

## Sources

- [S02: 2020 American College of Rheumatology Guideline for the Management of Gout](https://pmc.ncbi.nlm.nih.gov/articles/PMC10563586/)
- [S03: NICE NG219: Gout, diagnosis and management, recommendations](https://www.nice.org.uk/guidance/ng219/chapter/Recommendations)
- [S09: DailyMed: Allopurinol tablets prescribing information](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=e11e94b9-d897-48ce-9a80-aa6b8b5fde02&type=display)

[S02]: https://pmc.ncbi.nlm.nih.gov/articles/PMC10563586/ "2020 American College of Rheumatology Guideline for the Management of Gout"
[S03]: https://www.nice.org.uk/guidance/ng219/chapter/Recommendations "NICE NG219: Gout, diagnosis and management, recommendations"
[S09]: https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=e11e94b9-d897-48ce-9a80-aa6b8b5fde02&type=display "DailyMed: Allopurinol tablets prescribing information"

## Educational scope

Gout Life provides general educational information, not medical advice, diagnosis, or treatment. Talk with a qualified healthcare professional about symptoms, medicines, and treatment decisions. Do not delay medical care because of information on this site. If you think you may have a medical emergency, call your local emergency number.